Literature DB >> 12615658

Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification.

Kerry L Tyson1, Joanne L Reynolds, Rosamund McNair, Qiuping Zhang, Peter L Weissberg, Catherine M Shanahan.   

Abstract

OBJECTIVE: Mineralization-regulating proteins are found deposited at sites of vascular calcification. However, the relationship between the onset of calcification in vivo and the expression of genes encoding mineralization-regulating proteins is unknown. This study aimed to determine the temporal and spatial pattern of expression of key bone and cartilage proteins as atherosclerotic calcification progresses. METHODS AND
RESULTS: Using reverse transcription-polymerase chain reaction on a panel of noncalcified and calcified human arterial samples, two classes of proteins could be identified: (1) Matrix Gla protein, osteonectin, osteoprotegerin, and aggrecan were constitutively expressed by vascular smooth muscle cells (VSMCs) in the normal vessel media but downregulated in calcified arteries whereas (2) alkaline phosphatase, bone sialoprotein, osteocalcin, and collagen II were expressed predominantly in the calcified vessel together with Cbfa1, Msx2, and Sox9, transcription factors that regulate expression of these genes. In the calcified plaque in situ hybridization identified subsets of VSMCs expressing osteoblast and chondrocyte-like gene expression profiles whereas osteoclast-like macrophages were present around sites of calcification.
CONCLUSIONS: These observations suggest a sequence of molecular events in vascular calcification beginning with the loss of expression by VSMCs, of constitutive inhibitory proteins, and ending with expression by VSMCs and macrophages of chondrocytic, osteoblastic, and osteoclastic-associated proteins that orchestrate the calcification process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615658     DOI: 10.1161/01.ATV.0000059406.92165.31

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  167 in total

Review 1.  Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis.

Authors:  Sharon M Moe; Neal X Chen
Journal:  Pediatr Nephrol       Date:  2003-10       Impact factor: 3.714

2.  Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis.

Authors:  Su-Li Cheng; Jian-Su Shao; Linda R Halstead; Kathryn Distelhorst; Oscar Sierra; Dwight A Towler
Journal:  Circ Res       Date:  2010-05-20       Impact factor: 17.367

Review 3.  The role of phosphorus in the development and progression of vascular calcification.

Authors:  Jessica Kendrick; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2011-09-28       Impact factor: 8.860

4.  Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.

Authors:  Yong Sun; Chang Hyun Byon; Kaiyu Yuan; Jianfeng Chen; Xia Mao; Jack M Heath; Amjad Javed; Kui Zhang; Peter G Anderson; Yabing Chen
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

Review 5.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

Review 6.  The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature.

Authors:  Keith A Hruska; Suresh Mathew; Richard J Lund; Imran Memon; Georges Saab
Journal:  Semin Nephrol       Date:  2009-03       Impact factor: 5.299

7.  Bone morphogenetic proteins regulate osteoprotegerin and its ligands in human vascular smooth muscle cells.

Authors:  Kirsten Q T Nguyen; Ping Olesen; Thomas Ledet; Lars Melholt Rasmussen
Journal:  Endocrine       Date:  2007-09-29       Impact factor: 3.633

8.  Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.

Authors:  Rukshana C Shroff; Rosamund McNair; Jeremy N Skepper; Nichola Figg; Leon J Schurgers; John Deanfield; Lesley Rees; Catherine M Shanahan
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

9.  Diosgenin attenuates vascular calcification in chronic renal failure rats.

Authors:  Jeganathan Manivannan; T R Barathkumar; Jeganathan Sivasubramanian; Pandian Arunagiri; Boobalan Raja; Elumalai Balamurugan
Journal:  Mol Cell Biochem       Date:  2013-02-20       Impact factor: 3.396

Review 10.  Aspects of Hyperglycemia Contribution to Arterial Stiffness and Cardiovascular Complications in Patients With Type 1 Diabetes.

Authors:  Daniel Gordin; Per-Henrik Groop
Journal:  J Diabetes Sci Technol       Date:  2016-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.